Visiongain has published a new report entitled Automation in Biopharma Industry Market Report 2024-2034: Forecasts by Technology (Automation Technology,.
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical™ solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.
- Centralized data science platform streamlines clinical study data management for swift, insight-driven clinical decisions and therapeutic advancements- Seamless integration with Spotfire® for powerful visual analytics enabling flexibility, easy customization and scalability- Fosters cross-functional collaboration.